Company Data
Ampio Pharmaceuticals Inc.
Ticker
AMPE
Current Price
$0.252 -23.64%
Market Cap
$286.1K
Price Target
Refer to Report
Volume
938
52wk Range
$0.62 - $8.298
Overview
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company focused primarily on developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process and decreasing vascular permeability. Ampio’s leading product candidates are Ampion and Optina. It is currently conducting the second pivotal clinical trial in the United States for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.